Four Cases of Carbapenem-Resistant Enterobacteriaceae Infection from January to March in 2014

키워드

참고문헌 (8)

1. Perez F, "Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients", Cleve Clin J Med, 80, pp.225~233 (2013)
2. Zujic Atalic V, "Diversity of carbapenemases in clinical isolates of Enterobacteriaceae in Croatia: the results of a multicentre study", Clin Microbiol Infect, 20, pp.O894~O903 (2014)
3. Otter J, "Do you know your CRO from your CPO from your CRE from your CPE?", Micro Blog (2013)
4. Falagas ME, "Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae:systematic evaluation of the available evidence", Antimicrob Agents Chemother, 58, pp.654~663 (2014)
5. David M. Livermore, "Current Epidemiology and Growing Resistance of Gram- Negative Pathogens", The Korean Journal of Internal Medicine, 27(2), pp.128~142 (2012), 대한내과학회[DOI]
6. Nordmann P., "Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge", Med Mal Infect, 44, pp.51~56 (2014)
7. Munoz-Price LS, "Deconstructing the infection control bundles for the containment of carbapenem-resistant Enterobacteriaceae", Curr Opin Infect Dis, 26, pp.378~387 (2013)
8. Gupta N, "Carbapenem-resistant Enterobacteriaceae:epidemiology and prevention", Clin Infect Dis, 53, pp.60~67 (2011)

관련 논문AI추천